Cargando…
Comparison of Efficacy and Safety of Two Different Enoxaparin Products in Prevention of Venous Thromboembolism Following Major Obstetric-gynecological Surgeries: An Open-label Randomized Clinical Trial
Venous thromboembolism (VTE) occurs in about 5 percent of patients undergoing major abdominal surgeries. Prophylaxis of VTE is recommended using unfractionated heparin (UF) or low molecular weight heparin (LMWH) in high-risk patients. In spite of advantages and confirmed cost-effectiveness of LMWH,...
Autores principales: | Abdolvand, Manoochehr, Aleyasin, Ashraf, Javadi, Mohammad Reza, Solduzian, Mohammad, Hosseini, Seyed Hossein, Ziaei, Zohreh, Chaibakhsh, Samira, Gholami, Kheirollah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059046/ https://www.ncbi.nlm.nih.gov/pubmed/32184882 http://dx.doi.org/10.22037/ijpr.2019.111902.13417 |
Ejemplares similares
-
Prevention of venous thromboembolism with enoxaparin in bariatirc surgery
por: Woo, Hee Doo, et al.
Publicado: (2013) -
Safety of Enoxaparin as Venous Thromboembolism Prophylaxis After Rhytidectomy
por: Lisiecki, Jeffrey L., et al.
Publicado: (2019) -
Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism
por: Abdulla, Aliya, et al.
Publicado: (2023) -
Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in Low Body Weight Patients
por: Dybdahl, Daniel, et al.
Publicado: (2019) -
Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major
Gynecological Cancer Surgery: The VALERIA Trial: Venous thromboembolism
prophylAxis after
gynecoLogical pElvic cancer
surgery with RIvaroxaban versus
enoxAparin (VALERIA trial)
por: Longo de Oliveira, André Luiz Malavasi, et al.
Publicado: (2022)